New lens implants promise clear vision at all distances after cataract surgery

NCT ID NCT07161635

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests two types of advanced lens implants (IOLs) for people having cataract surgery in both eyes. The lenses are designed to help see clearly at far, arm's length, and near distances. Researchers will check safety and how well the lenses work in 110 participants over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Clareon PanOptix Pro and Pro Toric trifocal intraocular lenses (IOLs)
What this could lead to
If successful, this study could confirm that these IOLs provide reliable vision at far, arm's length, and near after cataract surgery.
What could go wrong
This is a post-market study with no control group, so results may not prove superiority over other lenses. Risks include typical cataract surgery complications like infection or inflammation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for APHAKIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Carolina Eyecare Physicians LLC

    Mt. Pleasant, South Carolina, 29464, United States

  • Houston Eye Associates

    Houston, Texas, 77008, United States

  • Moyes Eye Center

    Kansas City, Missouri, 64154, United States

  • The Eye Institute of Utah

    Salt Lake City, Utah, 84107, United States

  • Wolstan & Goldberg Eye Associates

    Torrance, California, 90505, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.